Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-dimensional1H MR Spectroscopy and MR Imaging: Clinicopathologic Case-controlled Study

MLA

Daniel B. Vigneron, et al. “Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-Dimensional1H MR Spectroscopy and MR Imaging: Clinicopathologic Case-Controlled Study.” Radiology, vol. 221, Nov. 2001, pp. 380–90. EBSCOhost, https://doi.org/10.1148/radiol.2211001582.

APA

Daniel B. Vigneron, Hedvig Hricak, Anita Srivastava, Imok Cha, John Kurhanewicz, Ryan G. Males, Mark G. Swanson, Juergen Scheidler, Ullrich G. Mueller-Lisse, André Bessette, & Peter R. Carroll. (2001). Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-dimensional1H MR Spectroscopy and MR Imaging: Clinicopathologic Case-controlled Study. Radiology, 221, 380–390. https://doi.org/10.1148/radiol.2211001582

Chicago

Daniel B. Vigneron, Hedvig Hricak, Anita Srivastava, Imok Cha, John Kurhanewicz, Ryan G. Males, Mark G. Swanson, et al. 2001. “Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-Dimensional1H MR Spectroscopy and MR Imaging: Clinicopathologic Case-Controlled Study.” Radiology 221 (November): 380–90. doi:10.1148/radiol.2211001582.